全球藥物釋放型支架市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球藥物釋放型支架市場預計將從2025年的93.3億美元成長至2034年的176.9億美元，2026年至2034年的複合年成長率（CAGR）為7.37%。心血管疾病盛行率的上升以及對微創治療方法需求的成長，推動了該市場的強勁成長。藥物釋放型支架廣泛用於預防動脈阻塞和減少血管成形術後的再血管再阻塞。人口老化、不健康的生活方式以及冠狀動脈疾病發生率的上升是推動產品需求成長的重要因素。支架塗層技術和生物可分解材料的進步也促進了全球市場的擴張。

公眾健康意識的提高和先進心臟治療可及性的改善是市場成長的關鍵促進因素。隨著藥物釋放型支架能夠改善患者預後並減少再次手術次數，醫院和醫療機構正在擴大其應用範圍。心血管研發投入的增加進一步加速了支架技術的創新。此外，支持性的健保報銷計畫和發展中地區不斷完善的醫療基礎設施也對市場滲透率產生了正面影響。

由於生物可吸收支架和精準心血管治療技術的持續進步，市場前景依然非常​​樂觀。對個人化治療方案和微創手術解決方案的日益重視預計將繼續創造成長機會。在新興市場，醫療保健支出的成長和心臟護理服務的改善預計將顯著推動需求成長。隨著全球心血管疾病盛行率的持續上升，預計該市場將在長期內保持穩定成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含多個關鍵組成部分，旨在幫助您全面了解市場環境。

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局概述。

市場動態：對影響市場成長的關鍵促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：本部分詳細評估了主要市場參與企業的市場定位、產品系列、策略舉措和財務表現。它提供了有關競爭對手趨勢和主要參與企業所採取的策略的寶貴見解。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為特定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，以更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新的投資機會。本部分重點在於潛在的成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，以更好地支持您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球藥物釋放型支架市場：依塗層類型分類

• 市場分析、洞察與預測
• 耐用聚合物
• 生物可吸收聚合物系統
• 不含聚合物

第5章 全球藥物釋放型支架市場：依材料分類

• 市場分析、洞察與預測
• 鈷鉻合金
• 鉑鉻合金
• 防鏽的
• 鎳鈦諾
• 鎂合金/複合材料

第6章 全球藥物釋放型支架市場：依藥物類型分類

• 市場分析、洞察與預測
• Sirolimus及其類似物（Everolimus、佐他莫司、比奧莫司 A9）
• 紫杉醇
• 雙藥/聯合藥物支架

第7章 全球藥物釋放型支架市場：依應用領域分類

• 市場分析、洞察與預測
• 冠狀動脈疾病
• 周邊動脈疾病

第8章：全球藥物釋放型支架市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 心臟導管介入/經皮冠狀動脈介入治療中心
• 門診手術中心

第9章 全球藥物釋放型支架市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和分銷通路合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott Laboratories
  • Alvimedica
  • B. Braun Melsungen AG
  • Balton Sp.zoo
  • Biosensors International Group Ltd
  • BIoTronik SE & Co. KG
  • Boston Scientific Corporation
  • Cook Medical Inc
  • Elixir Medical Corporation
  • Johnson & Johnson Services LLC
  • JW Medical Systems
  • Lepu Medical Technology Co. Ltd
  • Medtronic Plc
  • Meril Life Sciences Pvt. Ltd
  • MicroPort Scientific Corporation

The global drug-eluting stents market size is expected to reach USD 17.69 Billion in 2034 from USD 9.33 Billion in 2025, growing at a CAGR of 7.37 during 2026-2034.This market is witnessing strong growth due to increasing prevalence of cardiovascular diseases and rising demand for minimally invasive treatment procedures. Drug eluting stents are widely used to prevent artery blockage and reduce restenosis after angioplasty procedures. Growing aging populations, unhealthy lifestyles, and increasing incidence of coronary artery disease are significantly driving product demand. Technological advancements in stent coatings and biodegradable materials are also contributing to market expansion globally.

Increasing healthcare awareness and improved access to advanced cardiac treatments are major drivers supporting market growth. Hospitals and healthcare providers are increasingly adopting drug eluting stents because they improve patient outcomes and reduce repeat surgical interventions. Rising investments in cardiovascular research and development are further accelerating innovation in stent technologies. In addition, supportive reimbursement policies and expansion of healthcare infrastructure in developing regions are positively influencing market adoption.

Future prospects for the market remain highly favorable due to ongoing advancements in bioresorbable stents and precision cardiovascular therapies. Increasing focus on personalized treatment approaches and minimally invasive surgical solutions will continue creating growth opportunities. Emerging economies are expected to witness substantial demand growth due to rising healthcare expenditure and improving cardiac care services. As cardiovascular disease prevalence continues increasing worldwide, the market is projected to maintain steady long-term expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Coating Type

• Durable Polymer-based
• Bioresorbable Polymer-based
• Polymer-free

By Material

• CobaltChromium Alloy
• PlatinumChromium Alloy
• Stainless Steel
• Nitinol
• Magnesium Alloy / Composite

By Drug Type

• Sirolimus & Analogues (Everolimus, Zotarolimus, Biolimus A9)
• Paclitaxel
• Dual-therapy / Combination-drug Stents

By Application

• Coronary Artery Disease
• Peripheral Artery Disease

By End User

• Hospitals
• Cardiac Catheterization / PCI Centers
• Ambulatory Surgical Centers

COMPANIES PROFILED

• Abbott Laboratories, Alvimedica, B. Braun Melsungen AG, Balton Sp.z.o.o, Biosensors International Group Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Medical Inc., Elixir Medical Corporation, Johnson & Johnson Services LLC, JW Medical Systems, Lepu Medical Technology Co. Ltd., Medtronic plc, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DRUG ELUTING STENTS MARKET: BY COATING TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Coating Type
• 4.2. Durable Polymer-based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Bioresorbable Polymer-based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Polymer-free Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DRUG ELUTING STENTS MARKET: BY MATERIAL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Material
• 5.2. Cobalt-Chromium Alloy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Platinum-Chromium Alloy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Stainless Steel Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Nitinol Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Magnesium Alloy / Composite Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DRUG ELUTING STENTS MARKET: BY DRUG TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Drug Type
• 6.2. Sirolimus & Analogues (Everolimus, Zotarolimus, Biolimus A9) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Paclitaxel Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Dual-therapy / Combination-drug Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DRUG ELUTING STENTS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Coronary Artery Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Peripheral Artery Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL DRUG ELUTING STENTS MARKET: BY END USER 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End User
• 8.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Cardiac Catheterization / PCI Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL DRUG ELUTING STENTS MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Coating Type
  • 9.2.2 By Material
  • 9.2.3 By Drug Type
  • 9.2.4 By Application
  • 9.2.5 By End User
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Coating Type
  • 9.3.2 By Material
  • 9.3.3 By Drug Type
  • 9.3.4 By Application
  • 9.3.5 By End User
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Coating Type
  • 9.4.2 By Material
  • 9.4.3 By Drug Type
  • 9.4.4 By Application
  • 9.4.5 By End User
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Coating Type
  • 9.5.2 By Material
  • 9.5.3 By Drug Type
  • 9.5.4 By Application
  • 9.5.5 By End User
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Coating Type
  • 9.6.2 By Material
  • 9.6.3 By Drug Type
  • 9.6.4 By Application
  • 9.6.5 By End User
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL DRUG ELUTING STENTS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Abbott Laboratories
  • 11.2.2 Alvimedica
  • 11.2.3 B. Braun Melsungen AG
  • 11.2.4 Balton Sp.z.o.o
  • 11.2.5 Biosensors International Group Ltd
  • 11.2.6 Biotronik SE & Co. KG
  • 11.2.7 Boston Scientific Corporation
  • 11.2.8 Cook Medical Inc
  • 11.2.9 Elixir Medical Corporation
  • 11.2.10 Johnson & Johnson Services LLC
  • 11.2.11 JW Medical Systems
  • 11.2.12 Lepu Medical Technology Co. Ltd
  • 11.2.13 Medtronic Plc
  • 11.2.14 Meril Life Sciences Pvt. Ltd
  • 11.2.15 MicroPort Scientific Corporation